BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33986314)

  • 21. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
    Corn BW; Yousem DM; Scott CB; Rotman M; Asbell SO; Nelson DF; Martin L; Curran WJ
    Cancer; 1994 Nov; 74(10):2828-35. PubMed ID: 7954244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Executive dysfunction in delayed radiation-induced leukoencephalopathy.
    Henri-Bhargava A; Freedman M
    CMAJ; 2011 Sep; 183(12):1401. PubMed ID: 21690227
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis.
    Buglione M; Pedretti S; Gipponi S; Todeschini A; Pegurri L; Costa L; Donadoni L; Grisanti S; Fontanella M; Liserre R; Facchetti F; Padovani A; Magrini SM
    Radiol Med; 2014 Jun; 119(6):432-9. PubMed ID: 24297587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.
    Müller K; Scheithauer H; Pietschmann S; Hoffmann M; Rössler J; Graf N; Baumert BG; Christiansen H; Kortmann RD; Kramm CM; von Bueren AO
    Radiat Oncol; 2014 Aug; 9():177. PubMed ID: 25112658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed leukoencephalopathy of non-small cell lung cancer patients with brain metastases underwent whole brain radiation therapy.
    Zhong X; Huang B; Feng J; Yang W; Liu H
    J Neurooncol; 2015 Oct; 125(1):177-81. PubMed ID: 26275366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
    Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?
    Azizi AA; Paur S; Kaider A; Dieckmann K; Peyrl A; Chocholous M; Czech T; Slavc I
    Strahlenther Onkol; 2018 Jun; 194(6):552-559. PubMed ID: 29349602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma.
    Swennen MH; Bromberg JE; Witkamp TD; Terhaard CH; Postma TJ; Taphoorn MJ
    J Neurooncol; 2004 Feb; 66(3):333-9. PubMed ID: 15015665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
    Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
    Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy.
    Kamran SC; Dworkin M; Niemierko A; Bussiere M; Oh KS; Loeffler JS; Shih HA
    Pract Radiat Oncol; 2019; 9(4):e356-e361. PubMed ID: 30790717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
    Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
    Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
    Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of post-radiation injury: cerebral microinfarction not a significant factor.
    Molad JA; Blumenthal DT; Bokstein F; Findler M; Finkel I; Bornstein NM; Yust-Katz S; Auriel E
    J Neurooncol; 2017 Jan; 131(2):277-281. PubMed ID: 27757722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation-associated toxicities in the treatment of high-grade gliomas.
    Diaz AZ; Choi M
    Semin Oncol; 2014 Aug; 41(4):532-540. PubMed ID: 25173145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis.
    Eichberg DG; Di L; Morell AA; Shah AH; Semonche AM; Chin CN; Bhatia RG; Jamshidi AM; Luther EM; Komotar RJ; Ivan ME
    J Neurooncol; 2020 May; 147(3):671-679. PubMed ID: 32221785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.